Patrick Lin - Net Worth and Insider Trading
Patrick Lin Net Worth
The estimated net worth of Patrick Lin is at least $17,211 dollars as of 2025-04-27. Patrick Lin is the Chief Business - Strategy Off of Processa Pharmaceuticals Inc and owns about 72,559 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $17,211. Details can be seen in Patrick Lin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick Lin has not made any transactions after 2025-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patrick Lin
Patrick Lin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick Lin owns 1 companies in total, including Processa Pharmaceuticals Inc (PCSA) .
Click here to see the complete history of Patrick Lin’s form 4 insider trades.
Insider Ownership Summary of Patrick Lin
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2025-01-27 | Chief Business - Strategy Off |
Patrick Lin Latest Holdings Summary
Patrick Lin currently owns a total of 1 stock. Patrick Lin owns 72,559 shares of Processa Pharmaceuticals Inc (PCSA) as of January 27, 2025, with a value of $17,211.
Latest Holdings of Patrick Lin
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2025-01-27 | 72,559 | 0.24 | 17,211 |
Holding Weightings of Patrick Lin
Patrick Lin Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick Lin has made a total of 10 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Processa Pharmaceuticals Inc is the acquisition of 43,500 shares on January 27, 2025, which cost Patrick Lin around $34,800.
Insider Trading History of Patrick Lin
- 1
Patrick Lin Trading Performance
GuruFocus tracks the stock performance after each of Patrick Lin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick Lin is -2.82%. GuruFocus also compares Patrick Lin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick Lin within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patrick Lin's insider trading performs compared to the benchmark.
Performance of Patrick Lin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.81 | | | | | |
| Relative Return to S&P 500(%) | 0.57 | | | | | |
Patrick Lin Ownership Network
Ownership Network List of Patrick Lin
Ownership Network Relation of Patrick Lin
Patrick Lin Owned Company Details
What does Processa Pharmaceuticals Inc do?
Who are the key executives at Processa Pharmaceuticals Inc?
Patrick Lin is the Chief Business - Strategy Off of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include Chief Executive Officer George K Ng , director & 10 percent owner & President & CEO David Young , and Chief Administrative Officer Wendy Guy .
Processa Pharmaceuticals Inc (PCSA) Insider Trades Summary
Over the past 18 months, Patrick Lin made 2 insider transaction in Processa Pharmaceuticals Inc (PCSA) with a net purchase of 47,500. Other recent insider transactions involving Processa Pharmaceuticals Inc (PCSA) include a net purchase of 165,500 shares made by David Young , a net purchase of 97,200 shares made by George K Ng , and a net purchase of 20,400 shares made by Justin W Yorke .
In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc (PCSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc (PCSA) were sold and 330,600 shares were bought by its insiders, resulting in a net purchase of 330,600 shares.
Processa Pharmaceuticals Inc (PCSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Processa Pharmaceuticals Inc Insider Transactions
Patrick Lin Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick Lin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Patrick Lin's mailing address is: Hanover Md 21076.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
